Chemical structure and in vitro antitumor activity of rhamnolipids from pseudomonas aeruginosa BN10

Applied Biochemistry and Biotechnology

Volumn 170, Issue 3, 2013, Pages 676-689

  Christova, Neli ^a   Tuleva, Boryana ^a   Kril, Anton ^b   Georgieva, Milka ^c   Konstantinov, Spiro ^d   Terziyski, Ivan ^e   Nikolova, Biliana ^f   Stoineva, Ivanka ^g  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c National Oncology Center Bulgaria   (Bulgaria)

^d MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^e INSTITUTE OF PHYSICAL CHEMISTRY   (Bulgaria)

^f INSTITUTE OF BIOPHYSICS AND BIOMEDICAL ENGINEERING   (Bulgaria)

^g INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

Author keywords

Antitumor activity; ESI MS; NMR; Pseudomonas; Rhamnolipids

Indexed keywords

ANTI-TUMOR ACTIVITIES; APOPTOTIC CELL DEATH; ESI-MS; FLUORESCENT STAINING; HUMAN LEUKEMIA CELLS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RHAMNOLIPIDS;

BACTERIA; CELL CULTURE; CELL DEATH; CYTOTOXICITY; LIPIDS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; SILICA GEL; STRUCTURE (COMPOSITION);

SURFACE ACTIVE AGENTS;

ANTINEOPLASTIC AGENT; FLUORESCENT DYE; RHAMNOLIPID; RHAMNOLIPID 1; RHAMNOLIPID 2; SILICA GEL; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SEPARATION TECHNIQUE; T CELL LEUKEMIA;

ANIMALS; ANTINEOPLASTIC AGENTS; BALB 3T3 CELLS; CELL LINE, TUMOR; CELL SURVIVAL; GLYCOLIPIDS; HUMANS; LYMPHOCYTES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PSEUDOMONAS AERUGINOSA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SURFACE-ACTIVE AGENTS;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84878017778     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0225-z     Document Type: Article

References (33)

1. Desai, J. D.; & Banat, I. M. (1997). Microbiology and Molecular Biology Reviews, 61, 47-64.
2. Mulligan, C. N.; & Gibbs, B. F. (2004). Proceedings of the Indian National Science Academy, B70, 31-55.
3. Muthusamy, K. S.; Gopalakrishman, S.; Ravi, T. K.; & Sivachidambaram, P. (2008). Current Science, 94, 736-747.
4. Cameotra, S. S.; & Makkar, R. S. (1998). Applied Microbiology and Biotechnology, 50, 51-59.
5. Ron, E. Z.; & Rosenberg, E. (2001). Environmental Microbiology, 3, 229-236.
6. Banat, I. M.; Makkar, R.; & Cameotra, S. (2000). Applied Microbiology and Biotechnology, 53, 495-508.
7. Abalos, A.; Pinaso, A.; Infante, M. R.; Casals, M.; Garcia, F.; & Manresa, A. (2001). Langmuir, 17, 1367-1371.
8. Abalos, A.; Vinas, M.; Sabate, J.; Manresa, A.; & Solanas, A. M. (2004). Biodegradation, 15, 249-260.
9. Urum, K.; Grigson, S.; Pekdemir, T.; & McMenamy, S. (2006). Chemosphere, 62, 1403-1410.
10. Thanomsub, B.; Pumeechockchai, W.; Limtrakul, A.; Arunrattiyakorn, P.; Petchleelaha, W.; Nitoda, T.; et al. (2006). Bioresource Technology, 9, 2457-2461.
11. Benincasa, M.; Abalos, A.; Oliveira, I.; & Manresa, A. (2004). Antonie Van Leeuwenhoek, 85, 1-8.
12. Tuleva, B.; Christova, N.; Cohen, R.; Stoev, G.; & Stoineva, I. (2008). Journal of Applied Microbiology, 104, 1703-1710.
13. Bergey, D.H. & Holt, J.G. (1994). Bergey's manual of determinative bacteriology (9th ed.) (pp. 93-94). Baltimore: Williams & Wilkins
14. Miller, L.; Dykes, L.; & Polesky, H. (1988). Nucleic Acids Research, 16, 1215.
15. Chandrasekaran, E.V.; & Bemiller, J.N. (1980). In Whistler R.L. (Ed.), Methods in carbohydrate chemistry (pp. 89-96). New York: Academic
16. Konstantinov, S. M.; Eibl, H.; & Berger, M. R. (1998). Cancer Chemotherapy and Pharmacology, 41, 210-216.
17. Mosmann, T. (1983). Journal of Immunological Methods, 65, 55-63.
18. Borenfreund, E.; & Puerner, J. A. (1985). Toxicology Letters, 24, 119.
19. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E. S.; Baehrecke, E. H.; et al. (2009). Cell Death and Differentiation, 16, 3-11.
20. Bodour, A. A.; Drees, K. P.; & Maier, R. M. (2003). Applied and Environmental Microbiology, 69, 3280-3287.
21. Itoch, A.; Tomato, F.; & Suzuki, T. (1971). The Journal of Antibiotics, 24, 855-859.
22. Haferburg, D.; Hommel, R.; Kleber, H. P.; Kluge, S.; Schuster, G.; & Zshiegner, H. J. (1987). Acta Biotechnologica, 7, 353-356.
23. Stanghellini, M. E.; & Miller, R. M. (1997). Plant Disease, 19, 4-12.
24. Häußbler, S.; von Neuhoff, N. R.; Nimtz, M.; & Steinmetz, I. (2003). Infection and Immunity, 10, 2970-2975.
25. Stipcevic, T.; Piljac, A.; & Piljac, G. (2005). Journal of Dermatological Science, 40, 141-143.
26. Piljac, G.; & Piljac, V. (1995). US Patent, 5, 466-675.
27. Piljac, G.; & Piljac, V. (1995). US Patent, 5, 455-232.
28. Stipcevic, T.; Piljac, A.; & Piljac, G. (2006). Burns, 32, 24-34.
29. Collins, S. J. (1987). Blood, 70, 1233-1244.
30. Hurst, C. D.; Tomlinson, D. C.; Williams, S. V.; Platt, F. M.; & Knowles, M. A. (2008). Oncogene, 27, 2716-2727.
31. Kaufmann, S. H.; & Hengarther, M. O. (2001). Trends in Cell Biology, 262, 526-534.
32. Reed, J. (2003). Cancer Cells, 3, 17-25.
33. Arlinghaus, R.B.; invited guest editor. (2002), Oncogene (Review), 21, 8560-8567.